Earlier this year Oma Fertility, a company focused on using AI-enabled technology to improve IVF outcomes, announced the opening of its first fertility clinic in California and a $37.5M funding round. At the time the company also shared its plans to build a fertility clinic network in the U.S. and is making the first step in that direction today.
Oma Fertility has acquired New York Reproductive Wellness (NYRW), a fertility clinic in Syosset, New York. This acquisition will offer embryologists access to Oma Fertility’s proprietary AI technology, provide patients with an enhanced clinic experience, and will make fertility services, including in vitro fertilization (IVF) and egg freezing services accessible to more parents to-be. Oma is currently also preparing the opening of another clinic in New York City, which is set to open in January 2023.
NYRW is currently run by Dr. Gregory Zapantis and a team of experienced care providers. NYRW will retain its identity through 2022 as the clinic fully transitions its operations and technology into Oma Fertility’s centralized teams in January 2023. That transition will include: complete access to proprietary AI technology that aids embryologists in selecting the most promising sperm cell for use in IVF, ethically priced fertility services, and human-centered care with full access to nurses and a fully dedicated care team.
Oma Fertility CCO Sahil Gupta explains: “When we met Dr. Zapantis it was clear that his care philosophy aligned with ours. He and his team focus on science, success and support delivered through hands-on care. The NYRW team is known to be kind and compassionate, attributes that align with the human-centered care that is core to the Oma brand. Coupled with our forthcoming clinic in New York City, NYRW will allow us to continue delivering on our mission of making parenthood possible for more people in the New York metropolitan area.”
NYRW’s Dr. Gregory Zapantis adds: “At NYRW, our patients come first and our ultimate goal is a successful pregnancy and to be able to offer the best experience possible. When we spoke with the Oma Fertility team, we knew immediately that there is a real need for their technology and care services at our location, and we’re thrilled to be the first location on Long Island to be able to adopt and benefit directly from Oma Fertility’s AI technology.”
Infertility is a growing problem in the US, among both men and women. According to the Centers for Disease Control and Prevention (CDC), approximately 19% of women in the US are infertile, and Cleveland Clinic research highlights 10% of all males in the US are infertile with their infertility rates increasing 2% YoY.